<i>In Vitro</i> Immunomodulatory Effects of <i>Inonotus obliquus</i> Extracts on Resting M0 Macrophages and LPS-Induced M1 Macrophages

Shen, Dayue; Feng, Yating; Zhang, Xilan; Liu, Jing; Gong, Le; Liao, Hui; Li, Rongshan

doi:https://doi.org/10.1155/2022/8251344

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Ethical Approval Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

Complementary and Alternative Therapies for Inflammatory Disease

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 8251344 | https://doi.org/10.1155/2022/8251344

In Vitro Immunomodulatory Effects of Inonotus obliquus Extracts on Resting M0 Macrophages and LPS-Induced M1 Macrophages

Dayue Shen,¹Yating Feng,¹Xilan Zhang,¹Jing Liu,¹Le Gong,¹Hui Liao,²and Rongshan Li³

Academic Editor: Xiang Liu

Received27 Jan 2022

Revised04 Apr 2022

Accepted11 Apr 2022

Published21 Apr 2022

Abstract

Background. Inonotus obliquus (Chaga) is a parasitic fungus that is distributed mainly in northeast China. Our literature research showed chaga polysaccharides have bilateral effects on tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels when they exert antitumor and antidiabetic activities. The current research tried to explore the influence of chaga extracts on inflammatory factors via macrophage polarization which has bilateral immune-regulation not only on healthy tissue homeostasis but also on pathologies. Methods. Chaga was extracted with 100°C water and precipitated with 80% ethanol. The extracts were studied on RAW264.7 macrophage at resting condition (M0) and lipopolysaccharide (LPS)-activated subtype (classic activated macrophage, M1). The IL-1β, TNF-α, nitric oxide (NO) level, and the protein expressions of M1 and alternative activated macrophage (M2) markers including IL-1β, inducible NO synthase (iNOS), mannose receptor (CD206), and arginase (Arg)-1 were compared. Results. The 100 g extracts contained 13.7 g polysaccharides and 1.9 g polyphenols. Compared with M0, the 50 μg/mL extracts increased NO level () and decreased CD206 and Arg-1 expression significantly (). The extracts at 100–200 μg/mL increased NO and TNF-α level (), but increased iNOS and IL-1β expression significantly (). Compared with M1, the extracts decreased NO level at 25, 50, 100, and 200 μg/mL and decreased IL-1β and TNF-α level at 100–200 μg/mL significantly (). At 25–200 μg/mL, the extracts significantly increased CD206 and Arg-1 expression and decreased IL-1β and iNOS expression separately (). Conclusions. Our research suggested that the bilateral effects of the chaga extracts on iNOS, IL-1β, and NO level on M0/M1 macrophages might be related with chaga polysaccharides and chaga polyphenols. Some in vivo anticancer and antidiabetic research of purified chaga polysaccharides related to macrophage differentiation should be conducted further.

1. Introduction

Inonotus obliquus, also known as chaga, is a parasitic fungus that grows on birch trees and belongs to the Hymenochaetaceae family [1]. They are mainly distributed in northeast China and northern Russia [2]. Since the 16^th century, this fungus has been used as food and medicine for the prevention and treatment of malignant tumors, diabetes, and cardiovascular diseases in Russia, Poland, and the Baltic countries [3]. Chaga has biologically active substances such as polysaccharides, polyphenols, and flavonoids, and has various biological activities such as antitumor, hypoglycemic, antioxidation, and immune stimulation [4, 5]. Based on PubMed, Scopus, Wanfang database (Wanfang), and China National Knowledge Infrastructure (CNKI), an extensive literature survey was conducted about the research of chaga and its active substances on different diseases. Figure 1(a) shows that most of the articles of chaga were on antidiabetes research, followed by anticancer research over the last 10 years (2012–2021). As the two main active ingredients in chaga, Figures 1(b) and 1(c) show that polysaccharides have more research papers than polyphenols in antidiabetes and anticancer research.

(a)

(b)

(c)

Both cancer and diabetes are immunology-related diseases [6, 7]. Cancer immunology is the most rapidly expanding field in cancer research with the emerging importance of immunity in cancer pathogenesis [6]. A potential immune-regulatory factor in cancer immunology might represent an alternative target for the treatment of cancers [8]. In the development of type 2 diabetes mellitus (T2DM), chronic inflammation plays an important role, and the proinflammatory environment maintained by the innate immunity, including macrophages and related cytokines, can be influenced by adaptive immunity [7]. Our further literature research detailed the relationships between immune-regulatory signaling pathways of chaga polysaccharides and their antidiabetic [9–14] and antitumor activities [15–21] in Figure 2.

Figure 2

Antidiabetes and anticancer research of chaga polysaccharides based on immune-related signaling pathways. Abbreviations: AMPK, adenosine monophosphate-activated protein kinase; Akt, protein kinase B; AOM, azoxymethane; Bax, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2; C/EBPα, CCAAT/enhancer-binding protein α; COX-2, cyclooxygenase-2; DKD, diabetic kidney disease; DM, diabetes mellitus; DSS, dextran sulfate sodium; ERK, extracellular signal-regulated kinase; GLUT4, glucose transporter protein 4; HFD, high fat diet; IL-1β, interleukin-1β; IL-2, interleukin-2; IL-18, interleukin-18; JNK, c-Jun N-terminal kinase; LKB1, liver kinase B 1; MAPK, mitogen-activated protein kinases; MMP-2, matrix metalloprotein-2; MMP-7, matrix metalloprotein-7; MMP-9, matrix metalloprotein-9; mTOR, mammalian target of rapamycin; NF-κB, nuclear factor κappa B; NLRP3, the nod-like receptor family protein 3; NO, nitric oxide; PARP, poly ADP-ribose polymerase; PI3K, phosphatidylinositol 3 kinase; PPARγ, peroxisome proliferator-activated receptors γ; T2DM, type 2 diabetes mellitus; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-α; STZ, streptozotocin.

From Figure 2, it was interesting to see the bilateral effects of chaga polysaccharides on the following cytokines: protein kinase B (Akt) and matrix metalloprotein-9 (MMP-9) levels were increased in antidiabetic activities [10, 12], but decreased in anticancer effects [18, 19]. Conversely, chaga polysaccharides decreased reactive oxygen species (ROS), interleukin (IL)-1β, and tumor necrosis factor (TNF)-α level in antidiabetic activities [9] but increased ROS, IL-1β, and TNF-α level in anticancer effects [16, 17]. Our previous study showed that both IL-1β and TNF-α are the markers of a classic activated macrophage (M1), which is polarized from resting macrophage (M0) by lipopolysaccharide (LPS) [22, 23]. Based on the above literature research and our previous study, we were interested in investigating the effects of chaga on different macrophage conditions such as M0 and M1 and thus inflammatory factors such as IL-1β and TNF-α.

Macrophages are bone marrow-derived leukocytes that are key for healthy tissue homeostasis but can also contribute to pathologies such as metabolic syndrome [24]. Broadly, a macrophage is divided into three phenotypes: M0, M1-like, and alternative activated macrophage (M2)-like [23]. M1 and M2 have different transcription profiles and act by eliminating bacteria, viruses, and fungi from the host or repairing the damage triggered by inflammation, respectively [25]. In this research, the protein expressions of two markers of M1 differentiation including IL-1β and inducible nitric oxide synthase (iNOS), and two markers of M2 polarization, mannose receptor (CD206), and arginase (Arg)-1 were determined by Western blotting, and the levels of IL-1β, TNF-α, and nitric oxide (NO) were also tested.

2. Materials and Methods

2.1. Preparation of Samples

Chaga was collected from Lvliang Mountains in Shanxi province. The process for chaga extracts is shown in Figure 3 and described briefly as follows.

The chaga was cut into coarse particles with a grain size of about 2-3 mm. The 1 kg chaga particles were soaked into 10 L distilled water (w/w: 1 : 10) at room temperature for 3 h and then boiled at hot water (100°C) [26] for 1 h. The supernatants were removed and the residue was extracted another two times for 30 min, respectively. The total supernatants were collected and precipitated by 80% ethanol (v/v) [27] at 4°C for 12 h. The precipitates were collected and dried at 0.07 MPa vacuum and 55 ± 1°C to a constant weight. These dried samples were used for further research on the contents of polysaccharides and polyphenols.

2.2. Analyses of Polysaccharides Content

2.2.1. Standard Curve of Total Sugar

The total sugar was tested with phenol-sulfuric acid method using glucose as the standard [28]. About 1.0 mg/mL D-glucose (Solarbio, Beijing) stock solution was pipetted in deionized water at final concentrations of 25, 30, 35, 40, 45, 50, 55, and 60 μg/mL in 2 mL total volume and mixed with 2 mL of 5% phenol solution (v/v) and 10 mL of concentrated sulfuric acid (Shidande, Shanghai, P.R. China) separately. The mixture was placed in a water bath at 80°C and kept for 30 min. It was then cooled to room temperature, and the A values were measured at 486 nm using a spectrophotometer (Persee, Beijing). The standard curve of total sugar was obtained using the A value as the ordinate and the concentration as the abscissa.

2.2.2. Standard Curve of Reducing Sugar

The reducing sugar was determined by 3,5-dinitrosalicylic acid (DNS) assay [29]. 50 mg of glucose (Solarbio, Beijing) was weighed accurately and dissolved in 100 mL deionized water, and 0.5 mg/mL glucose standard solution was prepared. Then 0.0, 0.6, 0.8, 1.0, 1.2, and 1.4 mL of the prepared glucose standard solution were added to 2.0, 1.4, 1.2, 1.0, 0.8, 0.6 mL deionized water, respectively, and mixed with 1.5 mL DNS (Shidande, Shanghai, P.R. China) reagent separately. The mixtures were boiled in a water bath at 100°C for 5 min, then quickly cooled with running water, and diluted to 10 mL, and the absorbances were measured at a wavelength of 540 nm. A standard curve of reducing sugar was drawn using glucose concentration as the ordinate and absorbance as the abscissa.

2.2.3. Determination of Polysaccharide Content

The dried extract was accurately weighed and dissolved in deionized water, and 0.2 mg/mL solution of the extract was made separately. Then, 2 mL of the 0.2 mg/mL solution was mixed as aforementioned. The values of the total sugar and the reducing sugar were calculated according to the standard curve obtained above. Finally, the total polysaccharides content was calculated from the reducing sugar subtracted from the total sugar.

2.3. Analyses of Polyphenol Content

Polyphenol content was analyzed using Folin–Ciocalteu method, which was optimized by response surface methodology [30]. Briefly, 20 μL of 1 mg/mL extract was mixed with 100 μL of Folin–Ciocalteu’s reagent and 1,580 μL of 50% EtOH. The above mixture was kept for 10 min in the dark. Then, 300 μL of an aqueous solution of 0.2 g/mL Na₂CO₃ was added and put back in the dark for 2 h with continuous stirring. Finally, the mixture was centrifuged at 10,000 g for 3 min and 200 μL of the extract was put in a Greiner microplate (Solarbio, Beijing). The absorbance was measured with the Infinite M200 PRO microplate spectrophotometer (Tecan Trading AG, Switzerland) at 765 nm. The polyphenol content was calculated according to a calibration curve made using gallic acid as the analytical standard.

2.4. Cell Source and Culture

The mouse macrophage RAW264.7 cell line was purchased from the Procell Life Science & Technology Co., Ltd. (Wuhan, China). According to the instructions, the cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Solarbio Science & Technology, Beijing, China) supplemented with 10% fetal bovine serum (FBS, Gibco BRL, Gaithersburg, MD, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Shanxi MiniBio Technology Co., Ltd, Shanxi, China) in a 5% CO₂ incubator at 37°C. The medium was replaced the next day.

2.5. Cytotoxicity of the Extracts with CCK-8 Assay

The relative survival rate of cells was detected and calculated by cell counting kit 8 (CCK-8) assay to indicate the cytotoxicity. RAW264.7 cells were seeded into 96-well plates at a density of 1 × 10⁶ cells/mL and cultured in a 10% FBS DMEM for 24 h. Following another 24 h treatment with the extracts at 0, 25, 50, 100, 200, and 400 μg/mL, the supernatants were removed, and each well was washed with PBS before the addition of 10% FBS DMEM and 10 μL CCK-8 reagent (Shanxi MiniBio Technology Co., Ltd, Shanxi, China). Cell viability was determined by measuring the absorbance at 450 nm using a microporous plate reader (Model 550; Bio-Rad Laboratories, Inc., Hercules, CA, USA) after an incubation period of 2 h at 37°C. The average optical density was determined by examining six wells per group.

2.6. The Effects of the Extracts on CD206, Arg-1, IL-1β, and iNOS Protein Expressions on M0/M1 Macrophages

The normal medium-treated cells were the M0 macrophages (resting macrophages) and the LPS-treated cells were the M1 macrophages (classic activated macrophages). The iNOS, IL-1β, CD206, and Arg-1 protein expressions were tested by Western blotting after the chaga extracts (chaga crude polysaccharides) were used at 25, 50, 100, and 200 μg/mL (CCP25, CCP50, CCP100, and CCP200) on M0 and M1 macrophages separately. The treated cells (1 × 10⁶ cells/ml) were removed from the culture media and lysed with RIPA lysis buffer from Solarbio Science & Technology (Beijing, China) for 30 min. The protein concentrations were determined using a BCA Protein Assay Kit from Solarbio Science & Technology (Beijing, China). Samples containing 50 μg of protein were resolved by 10% SDS-PAGE electrophoresis and transferred to polyvinylidene fluoride membranes (Millipore, Shanghai, China) in a buffer tank with platinum wire electrodes. After immersing the membranes in 5% nonfat dried milk (diluted in 0.1% (v/v) Tween-20 PBS) for 2 h at room temperature to block the nonspecific binding, the membranes were incubated overnight with a primary antibody against iNOS (Catalog No. 18985-1-AP, Proteintech, Wuhan, China) at 1 : 2000 dilution, a primary antibody against IL-1β (Catalog No. bs-0812R, Bioss, Beijing, China) at 1 : 1000 dilution, a primary antibody against CD206 (Catalog No. bs-21473R, Bioss, Beijing, China) at 1 : 1000 dilution, and a primary antibody against Arg-1 (Catalog No. 16001-1-AP, Proteintech, Wuhan, China) at 1 : 5000 dilution at 4°C. The membranes were washed four times (15 min each) and then incubated with the corresponding secondary IgG conjugated to HRP antibody (Catalog No. SA00001-2, Proteintech, Wuhan, China) at room temperature for 1 h. The results were finally analyzed by the Quantity One analysis system (Bio-Rad, Hercules, CA, USA). GAPDH at a dilution of 1 : 5000 (Catalog No. 10494-1-AP, Proteintech, Wuhan, China) was used as the internal loading control.

2.7. The Effects of the Extracts on IL-1β, TNF-α, and NO Levels on M0/M1 Macrophages

M0 macrophages (1 × 10⁶ cells/mL) and M1 macrophages (1 × 10⁶ cells/mL) were treated with CCP25, CCP50, CCP100, and CCP200 for 24 h separately. Cell supernatants were then harvested and centrifuged at 1,500 g for 10 min at 4°C. The IL-1β level was determined using an ELISA kit (Catalog No. MM-0040M1, Jiangsu Meimian Industrial Co., Ltd). The TNF-α level was determined using an ELISA kit (Catalog No. MM-0132M1, Jiangsu Meimian Industrial Co., Ltd). The absorbance was measured using a microplate reader (Model 550, Bio-Rad Laboratories, Inc.). Each sample underwent repeated testing three times.

The NO level was tested with the Griess assay. Nitrite, a stable end-product of NO metabolism, was measured using the Griess reaction. Culture media of the RAW 264.7 cells (100 μL) was mixed with an equal volume of Griess reagent (Yantai Science & Biotechnology Co. LTD, Yantai, China), followed by spectrophotometric measurement at 540 nm (Model 550, Bio-Rad Laboratories, Inc.). Nitrite concentrations in the culture media were determined by comparison with a sodium nitrite standard curve. All experiments were repeated three times.

2.8. Statistical Analysis

The SPSS 19.0 software (IBM, Armonk, NY, US) was used for statistical analysis. All the data were expressed as mean ± standard deviation (SD) of the mean. A two-sided Student’s t-test was used to analyze the differences between the two groups. One-way analysis of variance with Bonferroni’s posttest was used when more than two groups were present. A value of <0.05 was considered statistically significant.

3. Results

3.1. The Polysaccharides and Polyphenol Content

A total of 112.5 g of extracts was obtained from 1 kg of chaga, with an extraction rate of 11.3%. Using the phenol-sulfuric acid method, the content of polysaccharides in the extract was measured to be 13.7%, i.e., 100 g of the extract contained 13.7 g of polysaccharides. With Folin–Ciocalteu method, the results showed that 100 g extracts contained 1.9 g polyphenol.

3.2. The Cytotoxicity Results

CCK-8 results showed that the extracts at 400 μg/mL inhibited the growth of RAW 264.7 cells (cell viability: (67.7 ± 4.7)%), which had a significant difference compared to the extracts at 0 μg/mL ((100.0 ± 3.9)%, ) and was unsuitable for further tests. The cell viabilities of the CCP25, CCP50, CCP100, and CCP200 were (103.0 ± 4.6)%, (98.2 ± 5.8)%, (98.6 ± 6.2)%, and (97.3 ± 4.7)%, respectively, which had no significant difference compared to the extracts at 0 μg/mL and could be used for the following research.

3.3. The Results of the Extracts on CD206, Arg-1, IL-1β, and iNOS Protein Expressions in M0 Macrophages

Figures 4(a)–4(c) show the CD206, Arg-1, IL-1β and iNOS protein expression of CCP25, CCP50, CCP100, CCP200 on M0 macrophages. The analyses in Figures 4(d) and 4(e) indicated that compared to M0, CCP25 and CCP50 decreased CD206 expression significantly ( and ), and CCP50 decreased Arg-1 expression significantly (). In Figures 4(f) and 4(g), we could see that compared to M0, CCP50 and CCP100 significantly increased IL-1β expression ( and ), and CCP 25 and CCP 200 increased iNOS expression significantly (both: ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

Figure 4

Effects of CCP on CD206, Arg-1, IL-1β, and iNOS protein expressions in M0 macrophages. (a) CD206 protein expressions. (b) Arg-1 and IL-1β protein expressions. (c) iNOS protein expression. The results of CD206, Arg-1, IL-1β, and iNOS protein expressions were represented in (d), (e), (f), and (g), respectively. All results were expressed as a ratio with respect to M0 and represented as the mean ± SD in triplicate. ^#, CCP versus M0. CCP, chaga crude polysaccharides; CCP 25, CCP at 25 μg/mL; CCP 50, CCP at 50 μg/mL; CCP 100, CCP at 100 μg/mL; CCP 200, CCP at 200 μg/mL; CD206, mannose receptor; Arg-1, arginase-1; IL-1β, interleukin-1β; iNOS, inducible nitric oxide synthase; M0, resting macrophages.

Further analyses showed that the increased effect on IL-1β expression of CCP100 was better than CCP50 significantly (), and the increased effect on iNOS expression of CCP200 was better than CCP25 significantly ().

3.4. The Results of the Extracts on CD206, Arg-1, IL-1β, and iNOS Protein Expressions in M1 Macrophages

Figures 5(a)‒5(d) show that the protein expression results of CD206, Arg-1, IL-1β, and iNOS after M1 macrophages were intervened with CCP. Compared with the M0 macrophages, CD206 and Arg-1 protein expression decreased (, ) in Figures 5(e) and 5(f), while IL-1β and iNOS protein expression of M1 macrophages significantly increased (, ) in Figures 5(g) and 5(h).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 5

Effects of CCP on CD206, Arg-1, IL-1β, and iNOS protein expressions in M1 macrophages. (a) CD206 protein expressions. (b) Arg-1 protein expressions. (c) IL-1β protein expressions. (d) iNOS protein expression. The results of CD206, Arg-1, IL-1β, and iNOS were represented in (e), (f), (g), and (h), respectively. All results were expressed as a ration with respect to M0 control and represented as the mean ± SD in triplicate. ^#, M1 versus M0. , CCP versus M1. CCP, chaga crude polysaccharides; LPS, lipopolysaccharide; CCP 25, CCP at 25 μg/mL; CCP 50, CCP at 50 μg/mL; CCP 100, CCP at 100 μg/mL; CCP 200, CCP at 200 μg/mL; CD206, mannose receptor; Arg-1, arginase-1; IL-1β, interleukin-1β; iNOS, inducible nitric oxide synthase; M0, resting macrophages; M1, classic activated macrophages.

Compared with the M1 macrophages, significantly increasing effects of CCP50, CCP100, and CCP200 on CD206 expression could be seen in Figure 5(e) (, and ). Among the above three concentrations, CCP200 showed its best effects compared with CCP50 () and CCP100 ().

Also compared with the M1 macrophages, CCP25, CCP100, and CCP200 increased Arg-1 expression significantly (, and ), and CCP200 was better than CCP25 () and even better than M0 macrophages ().

Compared with the M1 macrophages again, CCP200 decreased IL-1β and iNOS expression significantly ( and ) and CCP100 decreased iNOS significantly (). The decreasing effect on iNOS of CCP200 was better than CCP100 ().

3.5. The Results of the Extracts on IL-1β, TNF-α, and NO Levels in M0 Macrophages

Compared with the NO level of the M0 macrophages ((2.7 ± 0.6) μM), CCP50 ((9.3 ± 3.2) μM), CCP100 ((14.2 ± 3.5) μM), and CCP200 ((18.6 ± 2.1) μM) all showed significant increasing effects on NO production (, and ). The increased NO production of CCP200 was significantly higher than CCP50 ().

Compared with the TNF-α level of M0 macrophages ((452.9 ± 36.3) pg/mL), both CCP100 ((570.5 ± 21.0) pg/mL) and CCP200 ((606.5 ± 86.1) pg/ml) showed significant increasing effects on TNF-α level ( and ).

3.6. The Results of the Extracts on IL-1β, TNF-α, and NO Levels in M1 Macrophages

Compared with the M0 macrophages, the NO production of M1 macrophages increased from (2.7 ± 0.6) μM to (86.9 ± 0.9) μM (), promoted IL-1β level in macrophages from (90.7 ± 6.7) pg/mL to (146.2 ± 7.9) pg/mL (), and elevated TNF-α content from (452.9 ± 36.3) pg/mL to (522.2 ± 45.7) pg/mL. Results are shown in Figures 6(a)–6(c).

(a)

(b)

(c)

Figure 6

Effects of CCP on nitric oxide production, IL-1β, and TNF-α level in M0 and M1 macrophages. (a) Nitrite (nitric oxide production) levels. (b) IL-1β levels. (c) TNF-α levels. Values were expressed as the mean ± SD of the mean (n = 3). ^#, M1 versus M0. , CCP versus M1. CCP, chaga crude polysaccharides; LPS, lipopolysaccharide; CCP 25, CCP at 25 μg/mL; CCP 50, CCP at 50 μg/mL; CCP 100, CCP at 100 μg/mL; CCP 200, CCP at 200 μg/mL; IL-1β, interleukin-1β; TNF-α, tumor necrosis factor-α; M0, resting macrophages; M1, classic activated macrophages.

In Figure 6(a), CCP25, CCP50, CCP100, and CCP200 all had significant effects on decreasing NO production in M1 macrophages (All: ). The decreasing effects of CCP200 showed significantly better results compared with CCP25 () and CCP50 ().

Compared with the IL-1β level of M1 macrophages in Figure 6(b), CCP at four tested concentrations all showed the decreasing effects, but only CCP100 ((109.5 ± 9.2) pg/mL) and CCP200 ((114.0 ± 10.0) pg/mL) showed significant effects ( and ).

Finally, on TNF-α level in Figure 6(c), CCP200 showed its decreasing effects significantly ((350.8 ± 6.9) pg/mL, ) when compared with M1 macrophages.

4. Discussion

Polysaccharides are among the most important members of the biopolymer family. They are natural macromolecules composed of monosaccharides. To date, more than 300 kinds of natural polysaccharide compounds have been identified. They are present in plants, microorganisms, and engage in a variety of physiological functions [31]. The crude extracts of the medicinal mushroom chaga have been used as effective traditional medicine to treat malicious tumors, gastritis, gastric ulcers, and other inflammatory conditions [32]. Our literature research in Figure 1 supported that among the extracts from chaga, polysaccharides are major bioactive components that possess antitumor, hypoglycemic, and anti-inflammation activities [33]. As we mentioned before, cancer and diabetes are both regarded as immunology-related diseases [6, 7]. Antitumor and hypoglycemic mechanisms related to immunomodulatory activities of chaga polysaccharides are further summarized in Figure 2.

Figure 2 shows that antitumor activities of chaga polysaccharides are achieved through multiple signals including but not limited to the activation of the nod-like receptor family protein 3 (NLRP3) inflammasome, nuclear factor κappa B(NF-κB)/mitogen-activated protein kinases (MAPK) pathway, liver kinase B 1(LKB1)/AMPK pathway, and the promoted effects on NO, TNF-α, and IL-1β level via above signals and immuno-stimulating effects [15–21]. Figure 2 also shows that in vivo hypoglycemic activities of chaga polysaccharides are confirmed by depressing oxidative stress, NF-κB/transforming growth factor (TGF)-β pathway, and PI3K/Akt pathway. Accordingly, their hypoglycemic activities are correlated with the inhibition of TNF-α, IL-1β, NF-κB, and ROS level [9–11]. Based on the above discussion, it seemed that chaga polysaccharides have bilateral immunomodulatory effects on TNF-α, IL-1β, etc. in the face of cancer and diabetes.

Water extraction and ethanol precipitation are popular methods to obtain crude polysaccharides from many fruiting bodies of mushrooms, such as Coriolus versicolor [34] and Grifola frondosa [35]. It was reported that I. obliquus polysaccharides could be initially purified via precipitation from an aqueous extract with 80% alcohol [36]. The chaga crude polysaccharides were obtained in our research with the above similar method and were further studied on macrophages at M0 resting condition and LPS-activated M1 subtype.

As pivotal immune stromal cells in the tumor microenvironment (TME), macrophages are extensively heterogeneous and exert both antitumor and protumor functions [37]. Tumor-associated macrophages (TAMs) are the critical components of tumors and play an important role in the development of the immunosuppressive TME. It was reported that the transition of TAMs from M2 to M1 is crucial for the immunotherapy of gastric cancer [38]. Some related research showed that polysaccharides isolated from the fruiting body of chaga was capable of promoting NO/ROS production, TNF-α secretion, and phagocytic uptake in macrophages RAW264.7 cells [16]. Figure 2 also shows that anticancer activities of chaga polysaccharides were related to increased NO, ROS, and TNF-α levels on macrophages [15, 16]. Our research confirmed for the first time in vitro that the elevated NO, TNF-α, and IL-1β levels of chaga crude polysaccharides might related to their activities in increasing M0 to M1 polarization and decreasing M2 polarization.

It was reported that the chaga polysaccharide can ameliorate azoxymethane/dextran sulfate sodium-induced colitis-associated cancer in mice [17]. Colon cancer is a common and deadly human digestive tract malignant tumor with a poor prognosis [39]. Triptolide is extracted from the traditional Chinese medicine Tripterygium wilfordii. Related research showed that triptolide-educated colon cancers retarded the macrophages’ polarization to anti-inflammatory M2 status by decreasing the expression of Arg-1 and CD206, the markers of M2 polarization [39]. Could chaga polysaccharide exert its anticancer activity by promoting M0 to M1 subtype and decreasing M0 to M2 polarization? Further in vivo research should be conducted.

T2DM is characterized by low-grade chronic inflammation and metabolic dysfunction, which is observed in all tissues involved in energy homeostasis. A substantial body of evidence has established an important role for macrophages in these tissues during the development of T2DM [40]. Some related in vivo research demonstrated that hyperglycemia could polarize macrophages toward M1 via overproducing ROS under inflammatory condition [41]. An animal study showed that the mechanism of fasudil on the diabetic nephropathy progression might be associated with its induction of M2 polarization and the reduction of M1 polarization and inflammation [42]. A novel macrophage-regulating drug was reported to accelerate wound healing in a diabetic mouse model by decreasing M1 activity and enriching M2 populations. Furthermore, the efficiency of this macrophage-regulating medicine was confirmed in a multicenter, evaluator-blinded, phase 3 randomized clinical trial, which was performed across the US, China, and Taiwan [43].

In recent years, research on M1/M2 differentiation of chaga extract has been explored, such as inonotsuoxide B, a tetracyclic triterpenoid extracted from chaga, was reported to have a regulation effect on macrophage polarization [44]. To the best of our knowledge, our current work was the first study on the effect of chaga crude polysaccharides on regulating M1 to M2 phenotype. Our previous research showed that the protective effects of two safflower-derived compounds on hyperglycaemic stress-induced renal podocyte apoptosis via modulating macrophage M1 to M2 polarization [23]. We will try a study on M1/M2 subtype on diabetic animal model with chaga-purified polysaccharide in our following research.

In Table 1, it was interesting to see that when tested on resting the macrophage, CCP50 targeted both the markers of M1 and M2 including CD206, Arg-1, and IL-1β to produce NO. CCP200 increased iNOS expression to elevate NO and TNF-α level. When tested on M1, CCP100 and CCP200 had effects on the markers of M1 and also M2, but CCP25 and CCP50 only increased the protein expressions of M2. The potential reason of the above results might be that the other active ingredients such as polyphenols and flavonoids also extracted simultaneously when aqueous extraction and alcoholic precipitation was used mainly for polysaccharides extraction [45]. Our research already confirmed that in addition to polysaccharides in the extracts, polyphenols were also present [46].

Some findings indicated that chaga polysaccharides exert immune-enhancing activity and other components in chaga also displayed antitumor activity [47]. Do different components have different effects on macrophage polarization? Further studies should probably focus on some purified compounds and their relationships with macrophage differentiation, such as inonotsuoxide B. The antitumor activity of inonotsuoxide B [48] and its regulation on macrophage polarization through sirtuin-1/endoplasmic reticulum stress axis [44] was explored.

In recent years, the structure determinations of chaga polysaccharides and their antitumor and antidiabetic research have already made some progress. The structure characterization and hypoglycaemic activities of two polysaccharides from I. obliquus were reported recently [49]. A novel water-soluble polysaccharide was isolated and purified from chaga. Its chemical characteristics and antitumor, immunoregulatory activity were also investigated [50]. With the help of experts in the chemical structure analysis, the structural characterization and immune activity screening of polysaccharides with different molecular weights [51] from chaga crude polysaccharides is being studied by our research team. The relationships of purified polysaccharides and their immunomodulatory roles related to macrophage polarization could have prospects.

5. Conclusions

Chaga, a parasitic fungus, has drawn more interest in recent years for its multiple pharmacological actions. According to our literature research, chaga polysaccharides play important roles in antitumor and antidiabetic activities. The resting macrophages can be polarized to M1 or M2 subtype, which play different immunomodulatory roles when macrophages exert anticancer and antidiabetic activities. Our current in vitro research suggested that the bilateral effects of the chaga extracts on TNF-α, IL-1β, and NO level on M0/M1 macrophages might be related to its contained polysaccharides and chaga polyphenols. Further anticancer and antidiabetic research of purified chaga polysaccharide and polyphenol related to macrophage polarization should be conducted in vivo.

Data Availability

The readers can access the data supporting the conclusions of the study from Figures 1–6 and Table 1. All those figures and tables are included within the manuscript. All authors declare that the data of the manuscripts can be verified from the results of the article, be replicated in the analysis, and be conducted in secondary analyses.

Ethical Approval

The authors declare there are no studies on human subjects, human data or tissue, or animals in this manuscript.

Conflicts of Interest

The authors declare there are no conflicts of interest.

Acknowledgments

This study was supported by Wu Jieping Medical Foundation (no. 320.6750.2021-08-10), Key R & D Project of Shanxi Province (International Scientific and Technological Cooperation, Independent Topics, no. 201903D421061), and Basic Research Program of Shanxi Province (no. 202103021224370).

References

K. C. Duru, E. G. Kovaleva, I. G. Danilova, and P. Bijl, “The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies,” Phytotherapy Research, vol. 33, no. 8, pp. 1966–1980, 2019.
View at: Publisher Site | Google Scholar
Y. Wang, L. Guo, C. Liu, Y. Zhang, and S. Li, “Total triterpenoid extraction from Inonotus obliquus using ionic liquids and separation of potential lactate dehydrogenase inhibitors via ultrafiltration high-speed countercurrent chromatography,” Molecules, vol. 26, no. 9, pp. 2467–2514, 2021.
View at: Publisher Site | Google Scholar
J. Kim, S. C. Yang, A. Y. Hwang, H. Cho, and K. T. Hwang, “Composition of triterpenoids in Inonotus obliquus and their anti-proliferative activity on cancer cell lines,” Molecules, vol. 25, no. 18, pp. 4066–4069, 2020.
View at: Publisher Site | Google Scholar
M. Wang, Z. Zhao, X. Zhou et al., “Simultaneous use of stimulatory agents to enhance the production and hypoglycaemic activity of polysaccharides from Inonotus obliquus by submerged fermentation,” Molecules, vol. 24, no. 23, pp. 4400–4414, 2019.
View at: Publisher Site | Google Scholar
K. A. Szychowski, B. Skóra, T. Pomianek, and J. Gmiński, “Inonotus obliquus-from folk medicine to clinical use,” Journal of Traditional and Complementary Medicine, vol. 11, no. 4, pp. 293–302, 2021.
View at: Publisher Site | Google Scholar
X. Fu, C. De Angelis, and R. Schiff, “Interferon signaling in estrogen receptor-positive breast cancer: a revitalized topic,” Endocrinology, vol. 163, no. 1, pp. 1–15, 2022.
View at: Publisher Site | Google Scholar
S. Zhang, X. Gang, S. Yang et al., “The alterations in and the role of the Th17/Treg balance in metabolic diseases,” Frontiers in Immunology, vol. 12, pp. 1–14, 2021.
View at: Publisher Site | Google Scholar
S. Rashid, D. Song, J. Yuan, B. H. Mullin, and J. Xu, “Molecular structure, expression, and the emerging role of siglec-15 in skeletal biology and cancer,” Journal of Cellular Physiology, vol. 237, no. 3, pp. 1711–1719, 2022.
View at: Publisher Site | Google Scholar
B. Z. Diao, W. R. Jin, and X. J. Yu, “Protective effect of polysaccharides from Inonotus obliquus on streptozotocin-induced diabetic symptoms and their potential mechanisms in rats,” Evidence-based Complementary and Alternative Medicine, vol. 2014, Article ID 841496, 5 pages, 2014.
View at: Publisher Site | Google Scholar
J. Wang, W. Hu, L. Li et al., “Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes,” PLoS One, vol. 12, no. 6, Article ID e0180476, 2017.
View at: Publisher Site | Google Scholar
Y. J. Chou, W. C. Kan, C. M. Chang et al., “Renal protective effects of low molecular weight of Inonotus obliquus polysaccharide (LIOP) on HFD/STZ-induced nephropathy in mice,” International Journal of Molecular Sciences, vol. 17, no. 9, pp. 1535–1617, 2016.
View at: Publisher Site | Google Scholar
J. Wang, C. Wang, S. Li et al., “Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway,” Biomedicine & Pharmacotherapy, vol. 95, pp. 1669–1677, 2017.
View at: Publisher Site | Google Scholar
Y. C. Sim, J. S. Lee, S. Lee et al., “Effects of polysaccharides isolated from Inonotus obliquus against hydrogen peroxide-induced oxidative damage in RINm5F pancreatic β-cells,” Molecular Medicine Reports, vol. 14, no. 5, pp. 4263–4270, 2016.
View at: Publisher Site | Google Scholar
J. I. Joo, D. H. Kim, and J. W. Yun, “Extract of chaga mushroom (Inonotus obliquus) stimulates 3T3-L1 adipocyte differentiation,” Phytotherapy Research, vol. 24, no. 11, pp. 1592–1599, 2010.
View at: Publisher Site | Google Scholar
Y. O. Kim, H. W. Park, J. H. Kim, J. Y. Lee, S. H. Moon, and C. S. Shin, “Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus,” Life Sciences, vol. 79, no. 1, pp. 72–80, 2006.
View at: Publisher Site | Google Scholar
D. P. Won, J. S. Lee, D. S. Kwon, K. E. Lee, W. C. Shin, and E. K. Hong, “Immunostimulating activity by polysaccharides isolated from fruiting body of Inonotus obliquus,” Molecules and Cells, vol. 31, no. 2, pp. 165–173, 2011.
View at: Publisher Site | Google Scholar
J. Li, C. Qu, F. Li et al., “Inonotus obliquus polysaccharide ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated cancer in mice via activation of the NLRP3 inflammasome,” Frontiers in Pharmacology, vol. 11, pp. 1–11, 2021.
View at: Publisher Site | Google Scholar
K. R. Lee, J. S. Lee, S. Lee et al., “Polysaccharide isolated from the liquid culture broth of Inonotus obliquus suppresses invasion of B16-F10 melanoma cells via AKT/NF-κB signaling pathway,” Molecular Medicine Reports, vol. 14, no. 5, pp. 4429–4435, 2016.
View at: Publisher Site | Google Scholar
K. R. Lee, J. S. Lee, Y. R. Kim, I. G. Song, and E. K. Hong, “Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway,” Oncology Reports, vol. 31, no. 5, pp. 2447–2453, 2014.
View at: Publisher Site | Google Scholar
S. Jiang, F. Shi, H. Lin et al., “Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis,” International Journal of Biological Macromolecules, vol. 151, pp. 1277–1286, 2020.
View at: Publisher Site | Google Scholar
B. Su, X. Yan, Y. Li, J. Zhang, and X. Xia, “Effects of Inonotus obliquus polysaccharides on proliferation, invasion, migration, and apoptosis of osteosarcoma cells,” Analytical Cellular Pathology, vol. 2020, Article ID 4282036, 7 pages, 2020.
View at: Publisher Site | Google Scholar
Y. Li, Y. Zhou, Y. Wang, R. Crawford, and Y. Xiao, “Synovial macrophages in cartilage destruction and regeneration-lessons learnt from osteoarthritis and synovial chondromatosis,” Biomedical Materials, vol. 17, no. 1, pp. 012001–012009, 2022.
View at: Publisher Site | Google Scholar
Y. Li, D. Zheng, D. Shen, X. Zhang, X. Zhao, and H. Liao, “Protective effects of two safflower derived compounds, kaempferol and hydroxysafflor yellow A, on hyperglycaemic stress-induced podocyte apoptosis via modulating of macrophage M1/M2 polarization,” Journal of Immunology Research, vol. 2020, Article ID 2462039, 11 pages, 2020.
View at: Publisher Site | Google Scholar
S. K. Wculek, G. Dunphy, I. Heras-Murillo, A. Mastrangelo, and D. Sancho, “Metabolism of tissue macrophages in homeostasis and pathology,” Cellular & Molecular Immunology, vol. 19, no. 3, pp. 384–408, 2022.
View at: Publisher Site | Google Scholar
E. M. Melo, V. L. S. Oliveira, D. Boff, and I. Galvão, “Pulmonary macrophages and their different roles in health and disease,” The International Journal of Biochemistry & Cell Biology, vol. 141, pp. 106095–106098, 2021.
View at: Publisher Site | Google Scholar
J. Fang, S. Gao, R. Islam, Y. Teramoto, and H. Maeda, “Extracts of phellinus linteus, bamboo (Sasa senanensis) leaf and chaga mushroom (Inonotus obliquus) exhibit antitumor activity through activating innate immunity,” Nutrients, vol. 12, no. 8, pp. 2279–2312, 2020.
View at: Publisher Site | Google Scholar
A. Smith, S. Javed, A. Barad et al., “Growth-inhibitory and immunomodulatory activities of wild mushrooms from north-central british columbia (Canada),” International Journal of Medicinal Mushrooms, vol. 19, no. 6, pp. 485–497, 2017.
View at: Publisher Site | Google Scholar
H. Liao, D. Jia, X. Zhao, D. Zheng, Y. Li, and R. Li, “Effects of chaga medicinal mushroom Inonotus obliquus (Agaricomycetes) extracts on NOS-cGMP-PDE5 pathway in rat penile smooth muscle cells,” International Journal of Medicinal Mushrooms, vol. 22, no. 10, pp. 979–990, 2020.
View at: Publisher Site | Google Scholar
H. T. Song, Y. Gao, Y. M. Yang et al., “Synergistic effect of cellulase and xylanase during hydrolysis of natural lignocellulosic substrates,” Bioresource Technology, vol. 219, pp. 710–715, 2016.
View at: Publisher Site | Google Scholar
C. Fanali, V. Gallo, S. Della Posta et al., “Choline hloride-lactic acid-based NADES as an extraction medium in a response surface methodology-optimized method for the extraction of phenolic compounds from Hazelnut skin,” Molecules, vol. 26, no. 9, pp. 1–15, 2021.
View at: Google Scholar
M. Yin, Y. Zhang, and H. Li, “Advances in research on immunoregulation of macrophages by plant polysaccharides,” Frontiers in Immunology, vol. 10, pp. 1–9, 2019.
View at: Publisher Site | Google Scholar
Y. Zhao and W. Zheng, “Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus,” Journal of Ethnopharmacology, vol. 265, 2021.
View at: Publisher Site | Google Scholar
Y. Lu, Y. Jia, Z. Xue, N. Li, J. Liu, and H. Chen, “Recent developments in Inonotus obliquus (chaga mushroom) polysaccharides: isolation, structural characteristics, biological activities and application,” Polymers, vol. 13, no. 9, pp. 1441–1521, 2021.
View at: Publisher Site | Google Scholar
X. Zhang, Z. Cai, H. Mao, P. Hu, and X. Li, “Isolation and structure elucidation of polysaccharides from fruiting bodies of mushroom coriolus versicolor and evaluation of their immunomodulatory effects,” International Journal of Biological Macromolecules, vol. 166, pp. 1387–1395, 2021.
View at: Publisher Site | Google Scholar
A. Zhang, J. Deng, S. Yu, F. Zhang, R. J. Linhardt, and P. Sun, “Purification and structural elucidation of a water-soluble polysaccharide from the fruiting bodies of the Grifola frondosa,” International Journal of Biological Macromolecules, vol. 115, pp. 221–226, 2018.
View at: Publisher Site | Google Scholar
Y. Han, S. Nan, J. Fan, Q. Chen, and Y. Zhang, “Inonotus obliquus polysaccharides protect against Alzheimer’s disease by regulating Nrf2 signaling and exerting antioxidative and antiapoptotic effects,” International Journal of Biological Macromolecules, vol. 131, pp. 769–778, 2019.
View at: Publisher Site | Google Scholar
W. Li, X. Wang, C. Li, T. Chen, and Q. Yang, “Exosomal non-coding RNAs: emerging roles in bilateral communication between cancer cells and macrophages,” Molecular Therapy, vol. 30, no. 3, pp. 1036–1053, 2022.
View at: Publisher Site | Google Scholar
Y. Yang, Y. Yang, M. Chen et al., “Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages,” Biomaterials Science, vol. 9, no. 19, pp. 6597–6608, 2021.
View at: Publisher Site | Google Scholar
X. Jiang, G. Cao, G. Gao, W. Wang, J. Zhao, and C. Gao, “Triptolide decreases tumor‐associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor‐derived CXCL12,” Journal of Cellular Physiology, vol. 236, no. 1, pp. 193–204, 2021.
View at: Publisher Site | Google Scholar
S. Russo, M. Kwiatkowski, N. Govorukhina, R. Bischoff, and B. N. Melgert, “Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites,” Frontiers in Immunology, vol. 12, pp. 1–17, 2021.
View at: Publisher Site | Google Scholar
B. Zhang, Y. Yang, J. Yi, Z. Zhao, and R. Ye, “Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis,” Journal of Periodontal Research, vol. 56, no. 5, pp. 991–1005, 2021.
View at: Publisher Site | Google Scholar
F. Xie, J. Lei, M. Ran et al., “Attenuation of diabetic nephropathy in diabetic mice by fasudil through regulation of macrophage polarization,” Journal of Diabetes Research, vol. 2020, Article ID 4126913, 11 pages, 2020.
View at: Publisher Site | Google Scholar
Y. Y. Huang, C. W. Lin, N. C. Cheng et al., “Effect of a novel macrophage-regulating drug on wound healing in patients with diabetic foot ulcers: a randomized clinical trial,” JAMA Network Open, vol. 4, no. 9, Article ID e2122607, 2021.
View at: Publisher Site | Google Scholar
N. Du, K. Wu, J. Zhang et al., “Inonotsuoxide B regulates M1 to M2 macrophage polarization through sirtuin-1/endoplasmic reticulum stress axis,” International Immunopharmacology, vol. 96, pp. 107603–107609, 2021.
View at: Publisher Site | Google Scholar
J. Ding, H. Zhang, Y. Tian, P. F. H. Lai, H. Xu, and L. Ai, “Rheological properties of Prunus persica exudate: potential effects of proteins and polyphenols,” International Journal of Biological Macromolecules, vol. 133, pp. 831–838, 2019.
View at: Publisher Site | Google Scholar
Y. Wang, F. Ouyang, C. Teng, and J. Qu, “Optimization for the extraction of polyphenols from Inonotus obliquus and its antioxidation activity,” Preparative Biochemistry & Biotechnology, vol. 51, no. 9, pp. 852–859, 2021.
View at: Publisher Site | Google Scholar
H. He, Y. Li, M. Fang, T. Li, Y. Liang, and Y. Mei, “Carbon source affects synthesis, structures, and activities of mycelial polysaccharides from medicinal fungus Inonotus obliquus,” Journal of Microbiology and Biotechnology, vol. 31, no. 6, pp. 855–866, 2021.
View at: Publisher Site | Google Scholar
T. Nakata, T. Yamada, S. Taji et al., “Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus,” Bioorganic & Medicinal Chemistry, vol. 15, no. 1, pp. 257–264, 2007.
View at: Publisher Site | Google Scholar
P. Liu, J. Xue, S. Tong, W. Dong, and P. Wu, “Structure characterization and hypoglycaemic activities of two polysaccharides from Inonotus obliquus,” Molecules, vol. 23, no. 8, pp. 1948–2015, 2018.
View at: Publisher Site | Google Scholar
Y. Chen, Y. Huang, Z. Cui, and J. Liu, “Purification, characterization and biological activity of a novel polysaccharide from Inonotus obliquus,” International Journal of Biological Macromolecules, vol. 79, pp. 587–594, 2015.
View at: Publisher Site | Google Scholar
K. Li, Y. X. Cao, S. M. Jiao, G. H. Du, Y. G. Du, and X. M. Qin, “Structural characterization and immune activity screening of polysaccharides with different molecular weights from astragali radix,” Frontiers in Pharmacology, vol. 11, pp. 1–18, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Dayue Shen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

776

Downloads

569

Citations